Acute and Late Toxicity in Radical Radiotherapy for Bladder Cancer

Clinical Oncology

Volumn 21, Issue 8, 2009, Pages 598-609

  Majewski, W ^a   Tarnawski, R ^a  

^a Institute of Oncology   (Poland)

Author keywords

Acute toxicity; bladder cancer; late toxicity; radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER DISEASE; CANCER RADIOTHERAPY; CANCER STAGING; COLONOSCOPY; CYSTOSCOPY; DISEASE SEVERITY; ELECTROCOAGULATION; ENTEROPATHY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LATENT PERIOD; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RECTOSCOPY; RISK ASSESSMENT; SCORING SYSTEM; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; TREATMENT WITHDRAWAL;

DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KINETICS; MALE; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 69449084370     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2009.04.008     Document Type: Article

References (43)

1. Cerevek J., Cufer T., Krageli B., Zakotnik B., and Stanonik M. Sequential transurethral surgery, multiple drug chemotherapy, and radiation for invasive bladder carcinoma: initial report. Int J Radiat Oncol Biol Phys 25 (1993) 777-782
2. Coppin C.M.L., Gospodarowicz M.K., James K., et al. Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. J Clin Oncol 14 (1996) 2901-2907
3. Cowan R.A., McBain C.A., Ryder W.D.J., et al. Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy. Int J Radiat Oncol Biol Phys 59 (2004) 197-207
4. Davidson S.E., Symonds R.P., Snee M.P., Upadhyay S., Habeshaw T., and Robertson A.G. Assessment of factors influencing the outcome of radiotherapy for bladder cancer. Br J Urol 66 (1990) 288-293
5. Duncan W., and Quilty P.M. The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage X-ray therapy. Radiother Oncol 7 (1986) 299-310
6. Horwich A., Dearnaley D., Huddart R., et al. A randomised trial of accelerated radiotherapy for localized invasive bladder cancer. Radiother Oncol 75 (2005) 34-43
7. Majewski W., Maciejewski B., Majewski S., Suwinski R., Miszczyk L., and Tarnawski R. Clinical radiobiology of stage T2-T3 bladder cancer. Int J Radiat Oncol Biol Phys 60 (2004) 60-70
8. Pollack A., Zagars G.K., and Swanson D.A. Muscle-invasive bladder cancer treated with external beam radiotherapy: prognostic factors. Int J Radiat Oncol Biol Phys 30 (1994) 267-277
9. Salminen E. External beam radiation treatment of urinary bladder carcinoma. Acta Oncol 29 (1990) 909-914
10. Shipley W.U., Winter K.A., Kaufman D.S., et al. Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03. J Clin Oncol 16 (1998) 3576-3583
11. Tester W., Caplan R., Heaney J., et al. Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802. J Clin Oncol 14 (1996) 119-126
12. Tonoli S., Bertoni F., de Stefani A., et al. Radical radiotherapy for bladder cancer: retrospective analysis of a series of 459 patients treated in an Italian institution. Clin Oncol (R Coll Radiol) 18 (2006) 52-59
13. Cole D.J., Durrant K.R., Roberts J.T., Dawes J.T.K., Yosef H., and Hopewell W. A pilot study of accelerated fractionation in the radiotherapy of invasive carcinoma of the bladder. Br J Radiol 65 (1992) 792-798
14. Moonen L., van der Voet H., Horenblas S., and Bartelink H. A feasibility study of accelerated fractionation in radiotherapy of carcinoma of the urinary bladder. Int J Radiat Oncol Biol Phys 37 (1997) 537-542
15. Joiner M.C., and Bentzen S.M. Time-dose relationships: the linear-quadratic approach. In: Steel G.G. (Ed). Basic clinical radiobiology (2002), Arnold, London
16. Cox D.R. Regression models and life-tables. J R Stat Soc B 34 (1972) 187-220
17. Bentzen S.M., Saunders M.I., Dische S., and Bond S.J. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial. Radiother Oncol 60 (2001) 123-135
18. Denham J.W., and Hauer-Jensen M. The radiotherapeutic injury-a complex wound. Radiother Oncol 63 (2002) 129-145
19. Hainau B., and Dombernowsky P. Histology and cell proliferation in human bladder tumors. Cancer 33 (1974) 115-126
20. Stewart F.A. Mechanism of bladder damage and repair after treatment with radiation and cytostatic drugs. Br J Cancer 53 (1986) 280-291
21. Dorr W., Eckhardt M., Ehme A., and Koi S. Pathogenesis of acute radiation effects in the urinary bladder. Strahlenther Oncol 174 Suppl III (1998) 93-95
22. Denham J.W., Hauer-Jensen M., Kron T., and Langberg C.W. Treatment-time-dependence models of early and delayed radiation injury in rat small intestine. Int J Radiat Oncol Biol Phys 48 (2000) 871-887
23. Cox J.D., Guse C., Asbell S., Rubin P., and Sause W.T. Tolerance of pelvic normal tissues to hyperfractionated radiation therapy: results of protocol 83-08 of the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 15 (1988) 1331-1336
24. Morrison R. The results of treatment of cancer of the bladder - a clinical contribution to radiobiology. Clin Radiol 26 (1975) 67-75
25. Quilty P.M., Duncan W., and Kerr G.R. Results of a randomised study to evaluate influence of dose on morbidity in radiotherapy for bladder cancer. Clin Radiol 36 (1985) 615-618
26. Vijayakumar S., Awan A., Karrison T., et al. Acute toxicity during external-beam radiotherapy for localized prostate cancer: comparison of different techniques. Int J Radiat Oncol Biol Phys 25 (1993) 359-371
27. Zelefsky M.J., Cowen D., Fuks Z., et al. Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma. Cancer 85 (1999) 2460-2468
28. Schultheiss T.E., Lee W.R., Hunt M.A., Hanlon A.R., Peter R.S., and Hanks G.E. Late GI and GU complications in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 37 (1997) 3-11
29. Michalowski A. On radiation damage to normal tissues and its treatment. I Growth factors. Acta Oncol 29 (1990) 1017-1023
30. Williams J., Chen Y., Rubin P., Finkelstein J., and Okunieff P. The biological basis of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13 (2003) 182-188
31. Bentzen S.M., Lundbeck F., Christensen L.L., and Overgaard J. Fractionation sensitivity and latency of late radiation injury to the mouse urinary bladder. Radiother Oncol 25 (1992) 301-307
32. Lievens Y., Vanuytsel L., Rijnders A., van Poppel H., and van der Schueren E. The time course of development of late side effects after irradiation of the prostate with multiple fractions per day. Radiother Oncol 40 (1996) 147-152
33. van der Aardweg G.J.M.J., and Hopewell J.W. The kinetics of repair for sublethal radiation-induced damage in the pig epidermis: an interpretation based on a fast and slow component of repair. Radiother Oncol 23 (1992) 94-104
34. Plataniotis G., Michalopoulos E., Kouvaris J., Vlahos L., and Papavasiliou C. A feasibility study of partially accelerated radiotherapy for invasive bladder cancer. Radiother Oncol 33 (1994) 84-87
35. Pos F.J., van Tienhoven G., Hulshof M.C.C.M., Koedooder K., and Gonzales D.G. Concomitant boost radiotherapy for muscle-invasive bladder cancer. Radiother Oncol 68 (2003) 75-80
36. Yavuz A.A., Yavuz M.N., Ozgur G.K., et al. Accelerated superfractionated radiotherapy with concomitant boost for invasive bladder cancer. Int J Radiat Oncol Biol Phys 56 (2003) 734-745
37. Pilepich M.V., Krall J.M., Sause W.T., et al. Correlation of radiotherapeutic parameters and treatment related morbidity in carcinoma of the prostate - analysis of RTOG study 75-06. Int J Radiat Oncol Biol Phys 13 (1987) 351-357
38. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21 (1991) 109-122
39. Rubin P., and Casarett G. A direction for clinical radiation pathology. The tolerance dose. Front Radiat Ther Oncol 6 (1972) 1-16
40. Chahal R., Sundaram S.K., Iddenden R., Forman D.F., Weston P.M.T., and Harrison S.C.W. A study of the morbidity, mortality and long-term survival following radical cystectomy and radical radiotherapy in the treatment of invasive bladder cancer in Yorkshire. Eur Urol 43 (2003) 246-257
41. Fokdal L., Hoyer M., Meldgaard P., and von der Maase H. Long-term bladder, colorectal and sexual functions after radical radiotherapy for urinary bladder cancer. Radiother Oncol 72 (2004) 139-145
42. Henningsohn L., Wijkstrom H., Dickman P.W., Bergmark K., and Steineck G. Distressful symptoms after radical radiotherapy for urinary bladder cancer. Radiother Oncol 62 (2002) 215-225
43. Caffo O., Fellin G., Graffer U., and Luciani L. Assessment of quality of life after cystectomy or conservative therapy for patients with infiltrating bladder carcinoma. Cancer 78 (1996) 1089-1097